4.6 Article

Synthesis, structures and in vitro cytotoxicity of some cationic cis-platinum(II) complexes containing chelating thiocarbamates

期刊

JOURNAL OF INORGANIC BIOCHEMISTRY
卷 105, 期 3, 页码 462-466

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jinorgbio.2010.08.010

关键词

Pt complexes; Cytotoxicity; cis geometry; X-ray structure; Thiocarbamate ligands

资金

  1. Fonds der Chemischen Industrie
  2. DFG

向作者/读者索取更多资源

The thiocarbamates 4-RC6H4NHC(S)NR2' (R = H, Cl; R' = Me, Et), 4-ClC6H4NHC(S)NR (NR = 2-pyridylpiperazine) react with cis-[PtCl2(PTA)(2)] (PTA = 1,3,5-triaza-7-phosphaadamantane) in the presence of base to afford the monocationic platinum(II) complexes cis-[Pt(SC(NR2')= NC6H4R)(PTA)(2)](+) (R = H, Cl; R' = Me, Et), cis-[Pt{SC (NR) = NC6H4Cl}(PTA)(2)](+) (NR = 2-pyridylpiperazine), which were isolated as their PF6 salts in high yields. The complexes were fully characterised spectroscopically and also by X-ray crystallography. Cytotoxicity of these complexes was studied in vitro in three human cancer cell lines (CH1, A549 and SW480) using the MTT assay. (C) 2010 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in Mice

Valentin Fuchs, Klaudia Cseh, Michaela Hejl, Petra Vician, Benjamin Neuditschko, Samuel M. Meier-Menches, Lukas Janker, Andrea Bileck, Natalie Gajic, Julia Kronberger, Martin Schaier, Sophie Neumayer, Gunda Koellensperger, Christopher Gerner, Walter Berger, Michael A. Jakupec, Michael S. Malarek, Bernhard K. Keppler

Summary: A series of highly lipophilic Cp-substituted molybdenocenes with different bioactive chelating ligands were synthesized and characterized. They showed significantly increased cytotoxic potency compared to non-Cp-substituted counterparts. In vivo experiments demonstrated tumor growth inhibition for the most active complex containing the thioflavone ligand, along with significant regulation of tubulin-associated and mitochondrial inner membrane proteins.

CHEMISTRY-A EUROPEAN JOURNAL (2023)

Article Chemistry, Analytical

Seawater analysis of engineered nanoparticles using ICP-MS-based technology: Addressing challenges with the development of reliable monitoring strategy

Olga V. Kuznetsova, Bernhard K. Keppler, Andrei R. Timerbaev

Summary: This study developed a unified protocol for the preparation of seawater samples for ICP-MS analysis of nanoparticles, which involved acidification and ultrafiltration to stabilize the particles and facilitate metal analysis. High-resolution ICP-MS method was used to achieve very low limits of detection.

TALANTA (2023)

Article Pharmacology & Pharmacy

Half-Sandwich Rhodium Complexes with Releasable N-Donor Monodentate Ligands: Solution Chemical Properties and the Possibility for Acidosis Activation

Janos P. Meszaros, Wolfgang Kandioller, Gabriella Spengler, Alexander Prado-Roller, Bernhard K. Keppler, Eva A. Enyedy

Summary: This study introduces half-sandwich Rh complexes that can be activated in the acidic, extracellular pH of tumor tissue, reducing the side effects and improving the efficacy of chemotherapy.

PHARMACEUTICS (2023)

Correction Pharmacology & Pharmacy

Recent Developments in the Field of Tumor-Inhibiting Metal Complexes (vol 9, pg 2078, 2003)

M. S. Galanski, V. B. Arion, M. A. Jakupec, B. K. Keppler

CURRENT PHARMACEUTICAL DESIGN (2023)

Article Pharmacology & Pharmacy

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform

Yvonne Lerchbammer-Kreith, Nadine S. Sommerfeld, Klaudia Cseh, Xian Weng-Jiang, Uchechukwu Odunze, Andreas G. Schaetzlein, Ijeoma F. Uchegbu, Mathea S. Galanski, Michael A. Jakupec, Bernhard K. Keppler

Summary: A new class of anticancer prodrugs was developed by combining platinum(IV) complexes with glycol chitosan polymers as drug carriers. The platinum(IV) complexes were synthesized and conjugated with degraded glycol chitosan (dGC) polymers of different chain lengths. These conjugates exhibited higher cytotoxicity and antiproliferative activity in cancer cell lines compared to platinum(IV) counterparts. In particular, a cisplatin(IV)-dGC conjugate showed the highest cytotoxicity, being 33 times more potent than the corresponding platinum(IV) complex and twice as potent as cisplatin. Biodistribution studies of an oxaliplatin(IV)-dGC conjugate also showed increased accumulation in the lung, suggesting potential for further activity studies.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes-A More Selective Anticancer Treatment?

Yvonne Lerchbammer-Kreith, Michaela Hejl, Petra Vician, Michael A. Jakupec, Walter Berger, Mathea S. Galanski, Bernhard K. Keppler

Summary: Based on their drug delivery properties and activity against tumors, PAMAM dendrimers were combined with platinum(IV) complexes to improve anticancer treatment. The conjugates showed faster reduction behavior compared to the platinum(IV) complexes and exhibited significantly increased cytotoxic activity in human cell lines. In vivo experiments demonstrated tumor growth inhibition and prolonged animal survival.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands

Theresa Mendrina, Isabella Poetsch, Hemma Schueffl, Dina Baier, Christine Pirker, Alexander Ries, Bernhard K. K. Keppler, Christian R. R. Kowol, Dan Gibson, Michael Grusch, Walter Berger, Petra Heffeter

Summary: Platinum compounds are effective treatment options for various cancer types, but their use is limited by side effects and drug resistance. A new multi-targeted platinum(IV) prodrug, cisPt(PhB)(2), has shown promising anticancer activity and the ability to overcome drug resistance mechanisms. The drug's mode of action is influenced by cellular fatty acid metabolism and mitochondrial activity. Specifically, it is more effective against cisplatin-resistant cancer cells with Warburg-like properties. This orally applicable prodrug has the potential to improve cancer treatment outcomes.

PHARMACEUTICS (2023)

Article Chemistry, Multidisciplinary

Insertion of (Bioactive) Equatorial Ligands into Platinum(IV) Complexes

Alexander Kastner, Hemma Schueffl, Patrick A. Yassemipour, Bernhard K. Keppler, Petra Heffeter, Christian R. Kowol

Summary: Platinum(IV) prodrugs are promising alternatives to platinum(II) anticancer therapeutics. This study investigated the reactivity and synthetic usability of a platinum(IV) complex with hydrolyzable equatorial ligands, and successfully synthesized stable platinum(IV) complexes suitable for long-circulating tumor-targeting strategies. Additionally, platinum(IV) complexes with equatorial maleimides were synthesized, showing prolonged plasma half-life and improved anticancer activity compared to oxaliplatin.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Correction Oncology

Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue (vol 7, pg 55, 2007 )

Mathea Sophia Galanski, Bernhard K. K. Keppler

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2023)

Article Oncology

A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo

Monika Caban, Bettina Koblmueller, Diana Groza, Hemma H. Schueffl, Alessio Terenzi, Alexander Tolios, Thomas Mohr, Marlene Mathuber, Kushtrim Kryeziu, Carola Jaunecker, Christine Pirker, Bernhard K. Keppler, Walter Berger, Christian R. Kowol, Petra Heffeter

Summary: Through chemical modifications, KP2187 has similar activity and action as other clinically used EGFR inhibitors, without interfering with EGFR binding. In vitro and in vivo experiments have shown that KP2187 can significantly inhibit tumor cell proliferation and activate the EGFR signaling pathway. Moreover, KP2187 has a high synergistic effect with VEGFR inhibitors, indicating its potential as a hypoxia-activated prodrug.

CANCER LETTERS (2023)

Correction Biochemistry & Molecular Biology

Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches (vol 12, pg 2075, 2005)

Mathea Sophia Galanski, Michael A. Jakupec, Bernhard K. Keppler

CURRENT MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Multi-action platinum(IV) prodrugs conjugated with COX-inhibiting NSAIDs

Xiao Liu, Dominik Wenisch, Philipp Dahlke, Paul M. Jordan, Michael A. Jakupec, Christian R. Kowol, Phil Liebing, Oliver Werz, Bernhard K. Keppler, Wolfgang Weigand

Summary: In recent decades, the close connection between inflammation and cancer has been recognized, leading to extensive studies on joint strategies involving chemotherapeutic and anti-inflammatory agents. In this study, novel Pt(IV) complexes based on cisplatin and oxaliplatin were synthesized, incorporating non-steroidal anti-inflammatory drugs (NSAIDs) and their carboxyl ester analogues. Certain cisplatin-based Pt(IV) complexes 22-30 exhibited increased cytotoxicity in human cancer cell lines compared to the Pt(II) drug. Complex 26, containing two aceclofenac moieties, displayed potent anticancer effects combined with anti-inflammatory properties.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Pharmacology & Pharmacy

Anticancer Tungstenocenes with a Diverse Set of (O,O-), (O,S-) and (O,N-) Chelates-A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models

Klaudia Cseh, Iker Berasaluce, Valentin Fuchs, Alexandra Banc, Andreas Schweikert, Alexander Prado-Roller, Michaela Hejl, Debora Wernitznig, Gunda Koellensperger, Michael A. Jakupec, Wolfgang Kandioller, Michael S. Malarek, Bernhard K. Keppler

Summary: This paper describes the synthesis, characterization and biological activity of tungstenocenes with different biologically active chelates, such as (O,O-), (S,O-) and (N,O-). The complexes were analyzed using various techniques, including NMR, mass spectrometry, spectroscopy and X-ray diffraction. Their stability, electrochemical behavior, cytotoxicity and mode of action were investigated. The results showed that complexes containing (S,O-) chelates exhibited higher activity than those with (O,O-) and (N,O-) chelates. Notably, two complexes with a W-S or W-O bond showed different distribution patterns and strong inhibitory effects in tumor spheroid models.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Human serum albumin as a copper source for anticancer thiosemicarbazones

Martin Schaier, Enrico Falcone, Tomas Prstek, Bertrand Vileno, Sonja Hager, Bernhard K. Keppler, Petra Heffeter, Gunda Koellensperger, Peter Faller, Christian R. Kowol

Summary: Thiosemicarbazones (TSCs) are biologically active compounds that have potential anticancer activity by chelating iron and targeting ribonucleotide reductase. Recent findings suggest that the stability and reduction properties of copper complexes are essential for the action of specific TSC derivatives. This study investigated the interaction between TSCs and human serum albumin (HSA) as a potential source of copper, and found that TSCs specifically chelate copper from HSA and form ternary HSA conjugates.

METALLOMICS (2023)

Article Biochemistry & Molecular Biology

Structure prediction of physiological bis(amino acidato)copper(II) species in aqueous solution: The copper(II) compounds with L-glutamine and L-histidine

Michael Ramek, Jasmina Sabolovic

Summary: This paper investigates the geometries, energy landscapes, and magnetic parameters of copper(II) amino acid compounds using density functional theory calculations. The results show that certain conformers with histaminate-like and glycine-like modes have low Gibbs free energies and high metal-binding affinities. The predicted conformations reproduce the experimental electron paramagnetic resonance parameters.

JOURNAL OF INORGANIC BIOCHEMISTRY (2024)

Article Biochemistry & Molecular Biology

Synthesis, characterization and discovery of multiple anticancer mechanisms of dibutyltin complexes based on salen-like ligands

Wei Tian, Wen Zhong, Zengyan Yang, Ling Chen, Shijie Lin, Yanping Li, Yuxing Wang, Peilin Yang, Xing Long

Summary: A series of novel dibutyltin complexes based on salen-like ligands were synthesized and characterized. Complex S03 showed excellent in vitro anticancer activity and induced cancer cell death through multiple mechanisms. This study reveals new mechanisms of organotin complexes and provides new insights into the development of organotin metal complexes as anticancer drugs.

JOURNAL OF INORGANIC BIOCHEMISTRY (2024)

Article Biochemistry & Molecular Biology

Structural motifs in the early metallation steps of Zn(II) and Cd(II) binding to apo-metallothionein 1a

Natalie C. Korkola, Martin J. Stillman

Summary: Many proteins require a metal cofactor for their function, and these metals play a role in protein folding. The study found that the metallation rates of different metal binding pathways are influenced by pH, with the less cooperative pathway being more affected by low pH conditions. Specific mixtures of structures are formed in the initial steps of metallation, and unfolding the disordered apo-MT structure hinders the formation of these preliminary structures. The compact conformation of the native apo-MT allows for rapid formation of metal-thiolate structures with high affinity, providing protection from oxidation.

JOURNAL OF INORGANIC BIOCHEMISTRY (2024)

Article Biochemistry & Molecular Biology

DFT mechanistic study of biomimetic diiron complex catalyzed dehydrogenation: Unexpected Fe(III)Fe(III)-1,1-μ-hydroperoxy active species for hydride abstraction

Boxuan Yang, Xitong Song, Binju Wang

Summary: The diiron active site plays a crucial role in catalytic transformations in both biological and chemical systems. Recent advancements in the field include the synthesis of biomimetic diiron catalysts inspired by the active structure of soluble methane monooxygenase (sMMO), which have been successfully applied to the dehydrogenation of indolines.

JOURNAL OF INORGANIC BIOCHEMISTRY (2024)

Article Biochemistry & Molecular Biology

Mitochondriotropic agents conjugated with NSAIDs through metal ions against breast cancer cells

Christina N. Banti, Angeliki A. Piperoudi, Catherine P. Raptopoulou, Vassilis Psycharis, Constantinos M. Athanassopoulos, Sotiris K. Hadjikakou

Summary: Two copper(I) polymorphs with mitochondria-targeting properties were successfully prepared via metal ion conjugation. These compounds showed promising activities in DNA binding, enzyme inhibition, and cancer cell inhibition. The molecular mechanisms of action were investigated.

JOURNAL OF INORGANIC BIOCHEMISTRY (2024)